Outstanding Reviewer Award
Dear Colleagues,
The Marine Drugs Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy given by reviewers in checking manuscripts submitted to the journal. It is thanks to their efforts that the high quality of the journal and quick submission-to-publication process are maintained. The median time to first decision is currently an impressive 15 days, and the median time to publication is 33 days, which is all because of you.
Please join us in congratulating the two referees below, who will receive the “Marine Drugs 2019 Outstanding Reviewer Awards” in recognition of the quantity, timeliness, and quality of their reviews in 2018–2019. Both winners will receive 500 CHF and a certificate for their outstanding review work.
Prof. Dr. Eva Zubia
Department of Organic Chemistry, Faculty of Marine and Environmental Sciences, University of Cadiz, Spain
Dr. Naoki Morita
National Institute of Advanced Industrial Science and Technology, Japan
Marine Drugs (ISSN 1660-3397) is the leading peer-reviewed, open-access journal on the research, development, and production of biologically and therapeutically active compounds from the sea, published monthly online by MDPI. The journal is covered by leading indexing services, including Science Citation Index Expanded (Web of Science; its 2018 Impact Factor is 3.772 (ranked in Q1, in JCR category “Chemistry, Medicinal”)) and in Scopus (CiteScore (2018 Scopus data): 4.57, which equals rank 14/146 in “Drug Discovery”). For further details, please refer to https://www.mdpi.com/journal/marinedrugs.
Kind Regards,
Marine Drugs Editorial Office
Winner
Award Committee
Winner
